Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial.
from Reuters: Science News https://ift.tt/2OYKZiy
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
from Reuters: Science News https://ift.tt/2OYKZiy
0 comments:
Post a Comment